您的购物车当前为空
Rovatirelin(亦称为S-0373)是一种新型合成化合物,其作用模仿甲状腺释放激素(TRH)。该化合物对人类TRH受体的亲和力(Ki=702nM)高于taltirelin(Ki=3877nM)。在大鼠蓝斑区(LC)急性分离的去甲肾上腺素神经元中,Rovatirelin能增加自发动作电位的发放。此外,Rovatirelin亦能增加运动活动。Rovatirelin可能作为口服治疗,对SCD患者具有潜在的治疗效果。
别名 Rovatirelin hydrate [JAN], Rovatirelin hydrate, G5O9D3ZK7O
Rovatirelin(亦称为S-0373)是一种新型合成化合物,其作用模仿甲状腺释放激素(TRH)。该化合物对人类TRH受体的亲和力(Ki=702nM)高于taltirelin(Ki=3877nM)。在大鼠蓝斑区(LC)急性分离的去甲肾上腺素神经元中,Rovatirelin能增加自发动作电位的发放。此外,Rovatirelin亦能增加运动活动。Rovatirelin可能作为口服治疗,对SCD患者具有潜在的治疗效果。

| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 10-14周 | |
| 50 mg | 待询 | 10-14周 |
TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
| 产品描述 | Rovatirelin (also known as S-0373) is a novel synthetic compound that mimics the action of thyrotropin-releasing hormone (TRH). This compound exhibits a higher affinity for human TRH receptors (Ki=702nM) compared to taltirelin (Ki=3877nM). In acutely isolated norepinephrine neurons of the rat locus coeruleus (LC), rovatirelin enhances the firing of spontaneous action potentials. Additionally, rovatirelin increases motor activity and may offer potential therapeutic benefits as an oral treatment for patients with SCD. |
| 别名 | Rovatirelin hydrate [JAN], Rovatirelin hydrate, G5O9D3ZK7O |
| 分子量 | 420.48 |
| 分子式 | C16H28N4O7S |
| CAS No. | 879122-87-9 |
| Smiles | O=C(N1[C@@H](CCC1)C)[C@@H](NC([C@@H]2[C@@H](OC(N2)=O)C)=O)CC3=CSC=N3.O.O.O |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. 实际储存温度请以COA为准 |
对于不同动物的给药剂量换算,您也可以参考 更多